
Apposite heads for autumn final close for third fund
Apposite Capital is heading for a final close for Apposite Healthcare Fund III in autumn 2021, according to a source close to the situation.
The fund was registered in December 2020, according to an SEC filing.
The fund has already made its first deal: the GP announced the acquisition of Switzerland-based contract research organisation 1Med in May 2021, as reported.
Apposite Capital held a final close for its predecessor vehicle, Apposite Healthcare Fund II, in June 2018 on £144.5m. The fund makes growth capital and buyout deals in the healthcare sector, deploying £10-20m per deal.
The LP base of Fund II comprises institutional investors from Europe, the UK, the US and Asia, including healthcare and education foundations and endowments, as well as GPs such as Nord KB and MUH Private Equity.
According to its website, the GP focuses on commercial-stage businesses based in the UK and Europe, and can invest up to £30m per deal, with the option to provide larger tickets with support from its investors.
The GP previously raised $200m for its debut fund, which held a final close in 2006.
Apposite declined to comment.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater